Cytovene Iv

Product manufactured by H2-Pharma, Llc

Application Nr Approved Date Route Status External Links
NDA019661 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Cytovene-Iv Is A Deoxynucleoside Analogue Cytomegalovirus (cmv) Dna Polymerase Inhibitor Indicated For The: Treatment Of Cmv Retinitis In Immunocompromised Adult Patients, Including Patients With Acquired Immunodeficiency Syndrome (aids). ( 1.1 ) Prevention Of Cmv Disease In Adult Transplant Recipients At Risk For Cmv Disease. ( 1.2 ) 1.1 Treatment Of Cmv Retinitis Cytovene-Iv Is Indicated For The Treatment Of Cytomegalovirus (cmv) Retinitis In Immunocompromised Adult Patients, Including Patients With Acquired Immunodeficiency Syndrome (aids) [see Clinical Studies (14.1) ] . 1.2 Prevention Of Cmv Disease In Transplant Recipients Cytovene-Iv Is Indicated For The Prevention Of Cmv Disease In Adult Transplant Recipients At Risk For Cmv Disease [see Clinical Studies (14.2) ].

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Ganciclovir Sodium GANCICLOVIR SODIUM ZINC1505

Comments